Come here, fellow walking messes. It's time to invest in a slim wallet tracker and some shoe bags for your dirty sneaks.

DexCom is transforming into the premium CGM provider with the lowest cost per patient-day and robust clinical evidence. Read ...

A cluster-randomized trial in Germany shows that an e-health supported multicomponent family program delivered in routine ...

Pancreatic Cancer Trials to Watch at ESMO 2026 / cancer, cancer care, Cancer research, cancer treatment, clinical trials, KRAS G12D, OncoDaily, Oncology, ...

We alerted readers to PCVX on October 27, 2025, when it was at $42.30. The stock gathered pace over successive months, ...

A few days ago a new game on the internet came out called Two-Minute Drill. Since then it’s taken the internet of football ...

Biomed Industries, Inc. Presents Positive Phase 2/3 Results of NA-921 for Rett Syndrome at World Pediatrics Conference, ...

Bank of America's $1.2B anti-money laundering fine masked strong core earnings of $1.08/share (vs. $1.10 expected) in Q3.

Ratatan, the rhythm roguelite from the original Patapon creators, launches version 1.0 on PS5, Nintendo Switch 2, Xbox Series ...

Harris County needs more than justices of the peace who are content with merely speeding along cases in Harris County’s ...

Caliway Biopharmaceuticals is moving CBL-514 into phase 3 after 69.60 percent of treated participants achieved at least 150 mL of subcutaneous fat reduction in phase 2 data presented on October 2, ...

First patient dosed in global Phase 2 study evaluating VVD-214, an oral Werner helicase (WRN) inhibitor, plus pembrolizumab ...